OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 12 citing articles:

Sinensetin suppresses breast cancer cell progression via Wnt/β-catenin pathway inhibition
Shengqian Zhu, Lifei Meng, Wei Peng, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 1, pp. 348-362
Open Access | Times Cited: 11

HOTAIR: A key regulator of the Wnt/β-catenin signaling cascade in cancer progression and treatment
Mohammed Ageeli Hakami, Ali Hazazi, Osama Abdulaziz, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154957-154957
Closed Access | Times Cited: 11

Overview of Wnt/β-Catenin Pathway and DNA Damage/Repair in Cancer
Silvina B. Nadin, F. Darío Cuello-Carrión, Niubys Cayado-Gutiérrez, et al.
Biology (2025) Vol. 14, Iss. 2, pp. 185-185
Open Access

Functionalized Carbon Dots With Intrinsic Wnt/β-Catenin Inhibition to Synergistically Promote 5-Fluorouracil Chemotherapy
Ziwei Yang, Mingyue Zhou, Tianpeng Yin, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1951-1964
Open Access

Analyzing genetic and epigenetic HORMAD alterations in breast cancer resistance and metastatic events
Adam Hermawan, Herwandhani Putri
Journal of Research in Pharmacy (2025) Vol. 29, Iss. 1, pp. 137-150
Open Access

PARylation-mediated post-transcriptional modifications in cancer immunity and immunotherapy
Kazuya Matsumoto, Yoshinori Matsumoto, Jun Wada
Frontiers in Immunology (2025) Vol. 16
Open Access

Delving into the Role of Receptor-like Tyrosine Kinase (RYK) in Cancer: In Silico Insights into Its Diagnostic and Prognostic Utility
Jessica Alejandra Zapata-García, Luis Felipe Jave‐Suárez, Adriana Aguilar‐Lemarroy
Journal of Molecular Pathology (2024) Vol. 5, Iss. 1, pp. 66-80
Open Access | Times Cited: 2

Targeting a key FAK-tor: the therapeutic potential of combining focal adhesion kinase (FAK) inhibitors and chemotherapy for chemoresistant non-small cell lung cancer
Emma Geijerman, Francesca Terrana, Godefridus J. Peters, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1103-1118
Closed Access | Times Cited: 2

Biofilm mediated integrin activation and directing acceleration of colorectal cancer
V. Saravanan, Vinoj Gopalakrishnan, Maria Infant Majula Shifani Mahendran, et al.
Apmis (2024) Vol. 132, Iss. 10, pp. 688-705
Closed Access

Therapeutic advances in the targeting of ROR1 in hematological cancers
Adrian Bogdan Țigu, Raluca Munteanu, Cristian Moldovan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access

LUCAT1-Mediated Competing Endogenous RNA (ceRNA) Network in Triple-Negative Breast Cancer
Deepak Verma, Sumit Siddharth, Ashutosh S. Yende, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1918-1918
Open Access

Page 1

Scroll to top